These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1455053)

  • 1. Complement proteins and complement inhibitors in Alzheimer's disease.
    McGeer PL; McGeer EG
    Res Immunol; 1992; 143(6):621-4. PubMed ID: 1455053
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of complement and complement regulatory proteins in glomerulonephritis.
    Quigg RJ
    Springer Semin Immunopathol; 2003 May; 24(4):395-410. PubMed ID: 12778335
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical complementology: recent progress and future trends.
    Morgan BP
    Eur J Clin Invest; 1994 Apr; 24(4):219-28. PubMed ID: 8050450
    [No Abstract]   [Full Text] [Related]  

  • 4. Complement in ischemia reperfusion injury.
    Riedemann NC; Ward PA
    Am J Pathol; 2003 Feb; 162(2):363-7. PubMed ID: 12547694
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of complement in Alzheimer's disease pathology.
    Emmerling MR; Watson MD; Raby CA; Spiegel K
    Biochim Biophys Acta; 2000 Jul; 1502(1):158-71. PubMed ID: 10899441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement: a brief review.
    Frank MM
    J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 1):411-20. PubMed ID: 2677090
    [No Abstract]   [Full Text] [Related]  

  • 7. Pro-inflammatory complement activation by the A beta peptide of Alzheimer's disease is biologically significant and can be blocked by vaccinia virus complement control protein.
    Daly J; Kotwal GJ
    Neurobiol Aging; 1998; 19(6):619-27. PubMed ID: 10192224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible role of membrane complement regulators in vasculitis.
    Daha MR
    Behring Inst Mitt; 1993 Aug; (92):184-90. PubMed ID: 7504449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiology and pathophysiology of complement: progress and trends.
    Morgan BP
    Crit Rev Clin Lab Sci; 1995; 32(3):265-98. PubMed ID: 7495498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [General comments on complement].
    Belisario A; Modiano A; Cipolla C; D'Antuono G
    G Clin Med; 1980 Mar; 61(3):169-76. PubMed ID: 7390090
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement and complement inhibitors: their role in autoimmune and inflammatory diseases.
    Sheerin NS; Sacks SH
    Curr Opin Nephrol Hypertens; 1998 May; 7(3):305-10. PubMed ID: 9617562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events.
    Tenner AJ
    Neurobiol Aging; 2001; 22(6):849-61. PubMed ID: 11754992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms by which the erythrocyte protects itself from complement damage.
    Nicholson-Weller A; Halperin JA
    Prog Clin Biol Res; 1989; 297():263-70; discussion 270-1. PubMed ID: 2479950
    [No Abstract]   [Full Text] [Related]  

  • 14. Membrane regulators of complement activation and their aberrant expression in disease.
    Asghar SS
    Lab Invest; 1995 Mar; 72(3):254-71. PubMed ID: 7898046
    [No Abstract]   [Full Text] [Related]  

  • 15. [Complement system: biological functions].
    Santaella ML
    Bol Asoc Med P R; 1981 May; 73(5):209-15. PubMed ID: 7034739
    [No Abstract]   [Full Text] [Related]  

  • 16. Yin and Yang: complement activation and regulation in Alzheimer's disease.
    Shen Y; Meri S
    Prog Neurobiol; 2003 Aug; 70(6):463-72. PubMed ID: 14568360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement in human diseases: looking towards the 21st century.
    Pascual M; French LE
    Immunol Today; 1995 Feb; 16(2):58-61. PubMed ID: 7888067
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches.
    Chen S; Frederickson RC; Brunden KR
    Neurobiol Aging; 1996; 17(5):781-7. PubMed ID: 8892352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic uses of recombinant complement protein inhibitors.
    Kalli KR; Hsu P; Fearon DT
    Springer Semin Immunopathol; 1994; 15(4):417-31. PubMed ID: 8153875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia complement control protein: multi-functional protein and a potential wonder drug.
    Jha P; Kotwal GJ
    J Biosci; 2003 Apr; 28(3):265-71. PubMed ID: 12734405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.